Diamonds and Dogs

1/29/21

Novavax (NVAX) jumps 64% to a six-year high Friday after the company reported its experimental coronavirus vaccine was nearly 90% effective in a final-phase test. The experimental, two-shot vaccine was 89.3% effective against Covid-19 in a U.K. study, Novavax's jab was also effective against the U.K. and South Africa variants of the virus that causes Covid-19.

Johnson & Johnson's (JNJ) drops 3% followng thier vaccine news.The J&J vaccine was 72% efficacious in the U.S., though globally the efficacy dropped to 66%. The difference in efficacy shows the gap in effectiveness against strains from South Africa and Brazil. In South Africa, the efficacy dropped to 57%, while in Latin America it was 66% effective. Many doctors hailed this news as a positive, but with Pfizer and Moderna effectiveness over 90%, the markets are not sure how useful the J&J vaccine will be.